Analysed Fortress Biotech Inc (FBIO:NASDAQ) News Sources
Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
Yahoo Finance
Fortress Biotech, Inc.: Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
FinanzNachrichten.de
Cyprium Therapeutics inks agreement to sell rare paediatric disease priority review voucher for $205 million
Pharmabiz
Fortress Biotech to Receive $205M as Cyprium Agrees Sale of Rare Pediatric Disease Priority Review Voucher
InvestorsHub on MSN
FBIO shares rally after unit sells priority review voucher for $205 million: Retail now pins hopes on gene therapy
Stocktwits on MSN
What is the current price of Fortress Biotech Inc (FBIO:NASDAQ)?
The current price of Fortress Biotech Inc (FBIO:NASDAQ) is $3.43.
Fortress Biotech Inc (FBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of Fortress Biotech Inc (FBIO:NASDAQ) since the previous trading day is $-0.12.
Fortress Biotech Inc (FBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of Fortress Biotech Inc (FBIO:NASDAQ) since the previous trading day is -3.38%.
What is This Week's average sentiment score for Fortress Biotech Inc (FBIO:NASDAQ)?
This Week's average sentiment score for Fortress Biotech Inc (FBIO:NASDAQ) is 84 out of 100.
What is This Week's average sentiment for Fortress Biotech Inc (FBIO:NASDAQ)?
This Week's sentiment for Fortress Biotech Inc (FBIO:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.